Accurate preoperative differentiation of benign and malignant thyroid nodules is critical for optimal patient management. However, conventional imaging modalities present inherent diagnostic limitations. To develop a non-contrast computed tomography-based machine learning model integrating radiomics and clinical features for preoperative thyroid nodule classification. This multicenter retrospective study enrolled 272 patients with thyroid nodules (376 thyroid lobes) from center A (May 2021-April 2024), using histopathological findings as the reference standard. The dataset was stratified into a training cohort (264 lobes) and an internal validation cohort (112 lobes). Additional prospective temporal (97 lobes, May-August 2024, center A) and external multicenter (81 lobes, center B) test cohorts were incorporated to enhance generalizability. Thyroid lobes were segmented along the isthmus midline, with segmentation reliability confirmed by an intraclass correlation coefficient (≥ 0.80). Radiomics feature extraction was performed using Pearson correlation analysis followed by least absolute shrinkage and selection operator regression with 10-fold cross-validation. Seven machine learning algorithms were systematically evaluated, with model performance quantified through the area under the receiver operating characteristic curve (AUC), Brier score, decision curve analysis, and DeLong test for comparison with radiologists interpretations. Model interpretability was elucidated using SHapley Additive exPlanations (SHAP). The extreme gradient boosting model demonstrated robust diagnostic performance across all datasets, achieving AUCs of 0.899 [95% confidence interval (CI): 0.845-0.932] in the training cohort, 0.803 (95%CI: 0.715-0.890) in internal validation, 0.855 (95%CI: 0.775-0.935) in temporal testing, and 0.802 (95%CI: 0.664-0.939) in external testing. These results were significantly superior to radiologists assessments (AUCs: 0.596, 0.529, 0.558, and 0.538, respectively; <i>P</i> < 0.001 by DeLong test). SHAP analysis identified radiomic score, age, tumor size stratification, calcification status, and cystic components as key predictive features. The model exhibited excellent calibration (Brier scores: 0.125-0.144) and provided significant clinical net benefit at decision thresholds exceeding 20%, as evidenced by decision curve analysis. The non-contrast computed tomography-based radiomics-clinical fusion model enables robust preoperative thyroid nodule classification, with SHAP-driven interpretability enhancing its clinical applicability for personalized decision-making.

This study aimed to develop a machine learning model using breast ultrasound images to improve the non-invasive differential diagnosis between Sclerosing Adenosis (SA) and Invasive Ductal Carcinoma (IDC). 2046 ultrasound images from 772 SA and IDC patients were collected, Regions of Interest (ROI) were delineated, and features were extracted. The dataset was split into training and test cohorts, and feature selection was performed by correlation coefficients and Recursive Feature Elimination. 10 classifiers with Grid Search and 5-fold cross-validation were applied during model training. Receiver Operating Characteristic (ROC) curve and Youden index were used to model evaluation. SHapley Additive exPlanations (SHAP) was employed for model interpretation. Another 224 ROIs of 84 patients from other hospitals were used for external validation. For the ROI-level model, XGBoost with 18 features achieved an area under the curve (AUC) of 0.9758 (0.9654-0.9847) in the test cohort and 0.9906 (0.9805-0.9973) in the validation cohort. For the patient-level model, logistic regression with 9 features achieved an AUC of 0.9653 (0.9402-0.9859) in the test cohort and 0.9846 (0.9615-0.9978) in the validation cohort. The feature "Original shape Major Axis Length" was identified as the most important, with its value positively correlated with a higher likelihood of the sample being IDC. Feature contributions for specific ROIs were visualized as well. We developed explainable, ultrasound-based machine learning models with high performance for differentiating SA and IDC, offering a potential non-invasive tool for improved differential diagnosis. Question Accurately distinguishing between sclerosing adenosis (SA) and invasive ductal carcinoma (IDC) in a non-invasive manner has been a diagnostic challenge. Findings Explainable, ultrasound-based machine learning models with high performance were developed for differentiating SA and IDC, and validated well in external validation cohort. Critical relevance These models provide non-invasive tools to reduce misdiagnoses of SA and improve early detection for IDC.

Radiomics is transforming medical imaging by extracting complex features that enhance disease diagnosis, prognosis, and treatment evaluation. However, traditional approaches face significant challenges, such as the need for manual feature engineering, high dimensionality, and limited sample sizes. This paper presents Radio DINO, a novel family of deep learning foundation models that leverage self-supervised learning (SSL) techniques from DINO and DINOV2, pretrained on the RadImageNet dataset. The novelty of our approach lies in (1) developing Radio DINO to capture rich semantic embeddings, enabling robust feature extraction without manual intervention, (2) demonstrating superior performance across various clinical tasks on the MedMNISTv2 dataset, surpassing existing models, and (3) enhancing the interpretability of the model by providing visualizations that highlight its focus on clinically relevant image regions. Our results show that Radio DINO has the potential to democratize advanced radiomics tools, making them accessible to healthcare institutions with limited resources and ultimately improving diagnostic and prognostic outcomes in radiology.

BackgroundInadequate pharmacologic stress may limit the diagnostic and prognostic accuracy of myocardial perfusion imaging (MPI). The splenic ratio (SR), a measure of stress adequacy, has emerged as a potential imaging biomarker. ObjectivesTo evaluate the prognostic value of artificial intelligence (AI)-derived SR in a large multicenter 82Rb-PET cohort undergoing regadenoson stress testing. MethodsWe retrospectively analyzed 10,913 patients from three sites in the REFINE PET registry with clinically indicated MPI and linked clinical outcomes. SR was calculated using fully automated algorithms as the ratio of splenic uptake at stress versus rest. Patients were stratified by SR into high ([&ge;]90th percentile) and low (<90th percentile) groups. The primary outcome was major adverse cardiovascular events (MACE). Survival analysis was conducted using Kaplan-Meier and Cox proportional hazards models adjusted for clinical and imaging covariates, including myocardial flow reserve (MFR [&ge;]2 vs. <2). ResultsThe cohort had a median age of 68 years, with 57% male patients. Common risk factors included hypertension (84%), dyslipidemia (76%), diabetes (33%), and prior coronary artery disease (31%). Median follow-up was 4.6 years. Patients with high SR (n=1,091) had an increased risk of MACE (HR 1.18, 95% CI 1.06-1.31, p=0.002). Among patients with preserved MFR ([&ge;]2; n=7,310), high SR remained independently associated with MACE (HR 1.44, 95% CI 1.24-1.67, p<0.0001). ConclusionsElevated AI-derived SR was independently associated with adverse cardiovascular outcomes, including among patients with preserved MFR. These findings support SR as a novel, automated imaging biomarker for risk stratification in 82Rb PET MPI. Condensed AbstractAI-derived splenic ratio (SR), a marker of pharmacologic stress adequacy, was independently associated with increased cardiovascular risk in a large 82Rb PET cohort, even among patients with preserved myocardial flow reserve (MFR). High SR identified individuals with elevated MACE risk despite normal perfusion and flow findings, suggesting unrecognized physiologic vulnerability. Incorporating automated SR into PET MPI interpretation may enhance risk stratification and identify patients who could benefit from intensified preventive care, particularly when traditional imaging markers appear reassuring. These findings support SR as a clinically meaningful, easily integrated biomarker in stress PET imaging.

Collecting pixel-level labels for medical datasets can be a laborious and expensive process, and enhancing segmentation performance with a scarcity of labeled data is a crucial challenge. This work introduces AugPaint, a data augmentation framework that utilizes inpainting to generate image-label pairs from limited labeled data. AugPaint leverages latent diffusion models, known for their ability to generate high-quality in-domain images with low overhead, and adapts the sampling process for the inpainting task without need for retraining. Specifically, given a pair of image and label mask, we crop the area labeled with the foreground and condition on it during reversed denoising process for every noise level. Masked background area would gradually be filled in, and all generated images are paired with the label mask. This approach ensures the accuracy of match between synthetic images and label masks, setting it apart from existing dataset generation methods. The generated images serve as valuable supervision for training downstream segmentation models, effectively addressing the challenge of limited annotations. We conducted extensive evaluations of our data augmentation method on four public medical image segmentation datasets, including CT, MRI, and skin imaging. Results across all datasets demonstrate that AugPaint outperforms state-of-the-art label-efficient methodologies, significantly improving segmentation performance.

Segmentation of brain structures from MRI is crucial for evaluating brain morphology, yet existing CNN and transformer-based methods struggle to delineate complex structures accurately. While current diffusion models have shown promise in image segmentation, they are inadequate when applied directly to brain MRI due to neglecting anatomical information. To address this, we propose Collaborative Anatomy Diffusion (CA-Diff), a framework integrating spatial anatomical features to enhance segmentation accuracy of the diffusion model. Specifically, we introduce distance field as an auxiliary anatomical condition to provide global spatial context, alongside a collaborative diffusion process to model its joint distribution with anatomical structures, enabling effective utilization of anatomical features for segmentation. Furthermore, we introduce a consistency loss to refine relationships between the distance field and anatomical structures and design a time adapted channel attention module to enhance the U-Net feature fusion procedure. Extensive experiments show that CA-Diff outperforms state-of-the-art (SOTA) methods.

BackgroundPrecise delineation of non-contrast-enhancing tumor (nCET) in glioblastoma (GB) is critical for maximal safe resection, yet routine imaging cannot reliably separate infiltrative tumor from vasogenic edema. The aim of this study was to develop and validate an automated method to identify nCET and assess its prognostic value. MethodsPre-operative T2-weighted and FLAIR MRI from 940 patients with newly diagnosed GB in four multicenter cohorts were analyzed. A deep-learning model segmented enhancing tumor, edema and necrosis; a non-local spatially varying finite mixture model then isolated edema subregions containing nCET. The ratio of nCET to total edema volume--the Diffuse Infiltration Index (DII)--was calculated. Associations between DII and overall survival (OS) were examined with Kaplan-Meier curves and multivariable Cox regression. ResultsThe algorithm distinguished nCET from vasogenic edema in 97.5 % of patients, showing a mean signal-intensity gap > 5 %. Higher DII is able to stratify patients with shorter OS. In the NCT03439332 cohort, DII above the optimal threshold doubled the hazard of death (hazard ratio 2.09, 95 % confidence interval 1.34-3.25; p = 0.0012) and reduced median survival by 122 days. Significant, though smaller, effects were confirmed in GLIOCAT & BraTS (hazard ratio 1.31; p = 0.022), OUS (hazard ratio 1.28; p = 0.007) and in pooled analysis (hazard ratio 1.28; p = 0.0003). DII remained an independent predictor after adjustment for age, extent of resection and MGMT methylation. ConclusionsWe present a reproducible, server-hosted tool for automated nCET delineation and DII biomarker extraction that enables robust, independent prognostic stratification. It promises to guide supramaximal surgical planning and personalized neuro-oncology research and care. Key Points- KP1: Robust automated MRI tool segments non-contrast-enhancing (nCET) glioblastoma. - KP2: Introduced and validated the Diffuse Infiltration Index with prognostic value. - KP3: nCET mapping enables RANO supramaximal resection for personalized surgery. Importance of the StudyThis study underscores the clinical importance of accurately delineating non-contrast-enhancing tumor (nCET) regions in glioblastoma (GB) using standard MRI. Despite their lack of contrast enhancement, nCET areas often harbor infiltrative tumor cells critical for disease progression and recurrence. By integrating deep learning segmentation with a non-local finite mixture model, we developed a reproducible, automated methodology for nCET delineation and introduced the Diffuse Infiltration Index (DII), a novel imaging biomarker. Higher DII values were independently associated with reduced overall survival across large, heterogeneous cohorts. These findings highlight the prognostic relevance of imaging-defined infiltration patterns and support the use of nCET segmentation in clinical decision-making. Importantly, this methodology aligns with and operationalizes recent RANO criteria on supramaximal resection, offering a practical, image-based tool to improve surgical planning. In doing so, our work advances efforts toward more personalized neuro-oncological care, potentially improving outcomes while minimizing functional compromise.

Early detection of glaucoma represents a vital factor in securing vision while the disease retains its position as one of the central causes of blindness worldwide. The current glaucoma screening strategies with expert interpretation depend on complex and time-consuming procedures which slow down both diagnosis processes and intervention timing. This research adopts a complex automated glaucoma diagnostic system that combines optimized segmentation solutions together with classification platforms. The proposed segmentation approach implements an enhanced version of U-Net++ using dynamic parameter control provided by GWO to segment optic disc and cup regions in retinal fundus images. Through the implementation of GWO the algorithm uses wolf-pack hunting strategies to adjust parameters dynamically which enables it to locate diverse textural patterns inside images. The system uses a CapsNet capsule network for classification because it maintains visual spatial organization to detect glaucoma-related patterns precisely. The developed system secures an evaluation accuracy of 95.1% in segmentation and classification tasks better than typical approaches. The automated system eliminates and enhances clinical diagnostic speed as well as diagnostic precision. The tool stands out because of its supreme detection accuracy and reliability thus making it an essential clinical early-stage glaucoma diagnostic system and a scalable healthcare deployment solution. To develop an advanced automated glaucoma diagnostic system by integrating an optimized U-Net++ segmentation model with a Capsule Network (CapsNet) classifier, enhanced through Grey Wolf Optimization Algorithm (GWOA), for precise segmentation of optic disc and cup regions and accurate glaucoma classification from retinal fundus images. This study proposes a two-phase computer-assisted diagnosis (CAD) framework. In the segmentation phase, an enhanced U-Net++ model, optimized by GWOA, is employed to accurately delineate the optic disc and cup regions in fundus images. The optimization dynamically tunes hyperparameters based on grey wolf hunting behavior for improved segmentation precision. In the classification phase, a CapsNet architecture is used to maintain spatial hierarchies and effectively classify images as glaucomatous or normal based on segmented outputs. The performance of the proposed model was validated using the ORIGA retinal fundus image dataset, and evaluated against conventional approaches. The proposed GWOA-UNet++ and CapsNet framework achieved a segmentation and classification accuracy of 95.1%, outperforming existing benchmark models such as MTA-CS, ResFPN-Net, DAGCN, MRSNet and AGCT. The model demonstrated robustness against image irregularities, including variations in optic disc size and fundus image quality, and showed superior performance across accuracy, sensitivity, specificity, precision, and F1-score metrics. The developed automated glaucoma detection system exhibits enhanced diagnostic accuracy, efficiency, and reliability, offering significant potential for early-stage glaucoma detection and clinical decision support. Future work will involve large-scale multi-ethnic dataset validation, integration with clinical workflows, and deployment as a mobile or cloud-based screening tool.

ObjectiveTo develop and validate machine learning (ML) models for objective and comprehensive quantification of sagittal craniosynostosis (SCS) severity, enhancing clinical assessment, management, and research.DesignA cross-sectional study that combined the analysis of computed tomography (CT) scans and expert ratings.SettingThe study was conducted at a children's hospital and a major computer imaging institution. Our survey collected expert ratings from participating surgeons.ParticipantsThe study included 195 patients with nonsyndromic SCS, 221 patients with nonsyndromic metopic craniosynostosis (CS), and 178 age-matched controls. Fifty-four craniofacial surgeons participated in rating 20 patients head CT scans.InterventionsComputed tomography scans for cranial morphology assessment and a radiographic diagnosis of nonsyndromic SCS.Main OutcomesAccuracy of the proposed Sagittal Severity Score (SSS) in predicting expert ratings compared to cephalic index (CI). Secondary outcomes compared Likert ratings with SCS status, the predictive power of skull-based versus skin-based landmarks, and assessments of an unsupervised ML model, the Cranial Morphology Deviation (CMD), as an alternative without ratings.ResultsThe SSS achieved significantly higher accuracy in predicting expert responses than CI (<i>P</i> < .05). Likert ratings outperformed SCS status in supervising ML models to quantify within-group variations. Skin-based landmarks demonstrated equivalent predictive power as skull landmarks (<i>P</i> < .05, threshold 0.02). The CMD demonstrated a strong correlation with the SSS (Pearson coefficient: 0.92, Spearman coefficient: 0.90, <i>P</i> < .01).ConclusionsThe SSS and CMD can provide accurate, consistent, and comprehensive quantification of SCS severity. Implementing these data-driven ML models can significantly advance CS care through standardized assessments, enhanced precision, and informed surgical planning.

The clinical diagnosis of clear cell renal cell carcinoma (ccRCC) primarily depends on histopathological analysis and computed tomography (CT). Although pathological diagnosis is regarded as the gold standard, invasive procedures such as biopsy carry the risk of tumor dissemination. Conversely, CT scanning offers a non-invasive alternative, but its resolution may be inadequate for detecting microscopic tumor features, which limits the performance of prognostic assessments. To address this issue, we propose a high-order correlation-driven method for predicting the survival of ccRCC using only CT images, achieving performance comparable to that of the pathological gold standard. The proposed method utilizes a cross-modal hypergraph neural network based on hypergraph transfer learning to perform high-order correlation modeling and semantic feature extraction from whole-slide pathological images and CT images. By employing multi-kernel maximum mean discrepancy, we transfer the high-order semantic features learned from pathological images to the CT-based hypergraph neural network channel. During the testing phase, high-precision survival predictions were achieved using only CT images, eliminating the need for pathological images. This approach not only reduces the risks associated with invasive examinations for patients but also significantly enhances clinical diagnostic efficiency. The proposed method was validated using four datasets: three collected from different hospitals and one from the public TCGA dataset. Experimental results indicate that the proposed method achieves higher concordance indices across all datasets compared to other methods.